Metabolism May Explain Sex-Specific Kidney Disease Outcomes Metabolism May Explain Sex-Specific Kidney Disease Outcomes
Increased Krebs cycle metabolism in men vs pyruvate accumulation in women may underlie sex differences in diabetic kidney disease outcomes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 6, 2024 Category: Consumer Health News Tags: Nephrology Source Type: news

FDA Clears First OTC Continuous Glucose Monitor
(MedPage Today) -- The first over-the-counter continuous glucose monitor (CGM) was cleared for use by adults with or without diabetes, the FDA announced on Tuesday. The Dexcom Stelo Glucose Biosensor System is an integrated CGM (iCGM) that will... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 6, 2024 Category: Primary Care Source Type: news

Real-World Data Show Abbott's FreeStyle Libre ® Systems and GLP-1 Medicines Work Better Together for People with Type 2 Diabetes
(Source: Abbott.com)
Source: Abbott.com - March 6, 2024 Category: Pharmaceuticals Source Type: news

Short Sleep Ups Type 2 Diabetes Risk, Even With Healthy Diet Short Sleep Ups Type 2 Diabetes Risk, Even With Healthy Diet
Getting fewer than 6 hours of sleep a night increased the risk compared with 8 hours or more, and eating less red meat and more fish, fruits, and vegetables did not change that.Medscape News UK (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 6, 2024 Category: Endocrinology Tags: Internal Medicine Source Type: news

High-Fiber Gut Microbe Makeover Aids Weight Loss High-Fiber Gut Microbe Makeover Aids Weight Loss
A fiber supplement of resistant starch achieved weight loss and insulin sensitivity in people with overweight or obesity, partially by changes in gut microbiota.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 6, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news

FDA Clears First OTC Continuous Blood Glucose Monitor
WEDNESDAY, March 6, 2024 -- The U.S. Food and Drug Administration on Tuesday approved the country ' s first continuous glucose monitor for type 2 diabetes. The new Dexcom Stelo Glucose Biosensor System, which will be available by summer, is intended... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 6, 2024 Category: General Medicine Source Type: news

Low Birth Weight and Overweight at 20 Raise T2D Risk 10-Fold Low Birth Weight and Overweight at 20 Raise T2D Risk 10-Fold
Overweight at age 20 years has a marked impact on an individual ' s risk of developing type 2 diabetes if they also have a low birth weight, suggests a study of Swedish men.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 6, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news

Healthcare practice experiences consistent patient growth through holistic approach
A doctor in the Dayton region is experiencing booming patient growth through a holistic approach toward pre-diabetes treatment. The growth, through word of mouth, has prompted the addition of two jobs at the practice and shows no signs of slowing down. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 6, 2024 Category: Pharmaceuticals Authors: DBJ Staff Source Type: news

FDA Approves First OTC Continuous Glucose Monitor FDA Approves First OTC Continuous Glucose Monitor
The Dexcom Stelo Glucose Biosensor System is for adults with or without diabetes who don ' t use insulin.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 6, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news

How Are Endos Handling Weight-Loss Drug Shortages? How Are Endos Handling Weight-Loss Drug Shortages?
Some endocrinologists have come up with creative solutions for patients struggling to obtain anti-obesity medications amidst increasing warnings about compounded pharmacies.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 6, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news

Lance Bass Opens Up About Being Diagnosed With Diabetes During COVID Pandemic
Lance Bass says he developed diabetes during the COVID-19 pandemic and is working on managing his condition. “I’m definitely conscious of my eating now,” the NSYNC member told People magazine while promoting his partnership with allergy medicine Allegra. “I’m learning what you can eat, when you…#lancebass #nsync #peoplemagazine #allegra #eatingwell #justintimberlakes (Source: Reuters: Health)
Source: Reuters: Health - March 5, 2024 Category: Consumer Health News Source Type: news

Diabetes Risk Rises for Folks Who Get Too Little Sleep
TUESDAY, March 5, 2024 -- Are you typically getting only a few hours sleep each night? Besides leaving you groggy all day, your insomnia could also be raising your odds for type 2 diabetes, new research shows.Compared to people who slept the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 5, 2024 Category: General Medicine Source Type: news

Cleerly CAD Staging System gets FDA nod
Cleerly's coronary artery disease (CAD) Staging System has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). The system is a noninvasive imaging-based investigational software device that analyzes features of coronary atherosclerosis, stenosis, and ischemia. It aims to support physicians with risk assessment for patients at risk of major adverse cardiovascular events (MACE), including heart attacks, before they happen. The Cleerly CAD Staging System was also accepted into the FDA’s Total Product Life Cycle Advisory Program (TAP) Pilot program, which helps companies make devic...
Source: AuntMinnie.com Headlines - March 5, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Thoracic Imaging Source Type: news

Roche launches top selling eye drug Vabysmo in India
Roche Pharma India launches Vabysmo, a medication for neovascular age-related macular degeneration and diabetic macular edema in India. The drug is cost-effective and collaborates with government and insurance companies for patient access. Vabysmo achieves global sales and offers durable treatment for retinal vision loss. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 5, 2024 Category: Pharmaceuticals Source Type: news

Fresh health warning over a lack of sleep as study finds getting fewer than six hours each night may raise the risk of type 2 diabetes
Swedish researchers, who tracked nearly 250,000 Brits, found that managing less than six hours each night was linked to a 16 per cent higher risk of developing the condition. (Source: the Mail online | Health)
Source: the Mail online | Health - March 5, 2024 Category: Consumer Health News Source Type: news